Zylox-Tonbridge Medical Technology acquires optimed
Zylox-Tonbridge Medical Technology agreed to acquire optimed. Reported deal value: Undisclosed. Status: Pending. Sector: medical technology. Target headquarters context: Ettlingen, Baden-Wuerttemberg, Germany.
This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.
Zylox - Tonbridge to acquire German medical technology company Optimed Salong Debbarma Mon, January 19, 2026 at 11 :34 AM GMT+1 2 min read Zylox - Tonbridge , a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology company Optimed
Deal timeline
This transaction is classified in medical technology. Figures and status may change as sources update.